Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver. (Q37907194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

main subject

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hynek Mergental

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Delawir Kahn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Luiz Albuquerque

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Juan Marrero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jean Nicolas Vauthey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Robert J Porte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

17 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

S90-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21796760%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: current management and perspectives for the future

8 February 2020

cites work

1 reference

Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal

21 January 2018

1 reference

Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.

21 January 2018

1 reference

Liver transplantation and conventional surgery for advanced hepatocellular carcinoma

21 January 2018

1 reference

The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis.

21 January 2018

1 reference

Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections

21 January 2018

1 reference

Hepatoma in the noncirrhotic liver

21 January 2018

1 reference

An analysis of 412 cases of hepatocellular carcinoma at a Western center

21 January 2018

1 reference

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

21 January 2018

1 reference

Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis

21 January 2018

1 reference

Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre

21 January 2018

1 reference

Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver

21 January 2018

1 reference

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver

21 January 2018

1 reference

Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.

21 January 2018

1 reference

Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series.

21 January 2018

1 reference

Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse

21 January 2018

1 reference

Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis

21 January 2018

1 reference

Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver

21 January 2018

1 reference

Resection of hepatocellular carcinoma in patients without cirrhosis

21 January 2018

1 reference

Current role of portal vein embolization/hepatic artery chemoembolization

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review

21 January 2018

1 reference

Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis

21 January 2018

1 reference

Role of liver transplantation in the treatment of unresectable liver cancer.

21 January 2018

1 reference

Surgical treatment of hepatocellular carcinoma in cirrhotic and noncirrhotic patients.

21 January 2018

1 reference

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

21 January 2018

1 reference

Fibrolamellar hepatocellular carcinoma in children and adolescents

21 January 2018

1 reference

Outcome of patients with fibrolamellar hepatocellular carcinoma.

21 January 2018

1 reference

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

21 January 2018

1 reference

Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy

21 January 2018

1 reference

Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference